Healthy Skepticism Library item: 11141

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Obias-Manno D, Scott PE, Kaczmarczyk J, Miller M, Pinnow E, Lee-Bishop L, Jones-London M, Chapman K, Kallgren D, Uhl K.
The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy.
J Womens Health (Larchmt) 2007 Jul; 16:(6):807-17
http://www.liebertonline.com/doi/abs/10.1089/jwh.2006.0135

Abstract:

In 1994, the Food and Drug Administration Office of Women’s Health (FDA-OWH) was created to provide leadership and policy direction for the Agency regarding issues of women’s health. Within its first year, the FDA-OWH established a science program for women’s health research, promoting the development of sound policy and regulation. In a little over a decade, the program has provided approximately $14 million to fund more than 100 women’s health research studies covering a broad range of health topics affecting women across their lifespan. Some studies, such as those elucidating drug effects on QT prolongation in women and drug-dietary supplement interaction, have had significant influence on regulatory decisions. Other studies have provided sound scientific data on sex and gender differences supporting FDA guidelines to protect women’s health. This paper describes the science program at the FDA-OWH, providing examples of how funded research impacts regulatory policy.

Keywords:
PMID: 17678451 [PubMed - in process]